Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Rapid and automated design of two-component protein nanomaterials using ProteinMPNN
2024 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
South African Health Review 2005.
2005 Standout
Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors
2003
Factors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS)
2009
No health without mental health
2007 Standout
Thiazolidinediones
2004 Standout
Steady‐state pharmacokinetics of once‐daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers*
2007
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Toxoplasmosis
2004 Standout
Acute hepatitis C and HIV coinfection
2009
Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases
2002
Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature
2002
Pharmacologic Optimization of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors (POPIN)-A Randomized Controlled Trial of Therapeutic Drug Monitoring and Adherence Support
2006
Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 Standout
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients
2007
Liver Transplantation in Hiv-Infected Recipients
2005
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Risk of Non-AIDS-Related Mortality May Exceed Risk of AIDS-Related Mortality Among Individuals Enrolling Into Care With CD4+ Counts Greater Than 200 Cells/mm3
2006
Glioblastoma and Other Malignant Gliomas
2013 Standout
The burden of non-communicable diseases in South Africa
2009 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Life expectancy living with HIV
2012
Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic
2009
Mitochondrial toxicity and HIV therapy
2001
Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review
2014
Is Sexual Contact a Major Mode of Hepatitis C Virus Transmission?
2010
Selenium and human health
2012 Standout
Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase
2001
AIDS DEMENTIA COMPLEX
1999
Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection
2003
Clinically relevant drug interactions with antiepileptic drugs
2005
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
Precipitation of Ventricular Fibrillation by Intravenous Diltiazem and Metoprolol in a Young Patient with Occult Wolff‐Parkinson‐White Syndrome
2008
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
2003 Standout
Treatment for Adult HIV Infection
2006
Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men
2012
Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus.
1995
Antibodies to DNA
1998
Adverse effects of antiretroviral therapy
2000
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Mitochondrion-mediated apoptosis in HIV-1 infection
2003
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
2013
Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS
2005
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Use of therapeutic drug monitoring in HIV disease
2008
Pharmacokinetics, Safety, and Efficacy of Tipranavir Boosted With Ritonavir Alone or in Combination With Other Boosted Protease Inhibitors as Part of Optimized Combination Antiretroviral Therapy in Highly Treatment-Experienced Patients (BI Study 1182.51)
2008
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Development of Anti‐dsDNA Autoantibodies Prior to Clinical Diagnosis of Systemic Lupus Erythematosus
2001
A 48-Week, Randomized, Open-Label Comparison of Three Abacavir-Based Substitution Approaches in the Management of Dyslipidemia and Peripheral Lipoatrophy
2003
Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.
1992 StandoutNobel
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Tenofovir Disoproxil Fumarate Therapy for Chronic Hepatitis B in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Individuals for Whom Interferon‐α and Lamivudine Therapy Have Failed
2002
Substance Abuse and Psychiatric Disorders in HIV-Positive Patients
2006
Hepatitis C Virus Infections in the Swiss HIV Cohort Study: A Rapidly Evolving Epidemic
2012
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loops
1992 StandoutNobel
Structural repertoire of the human VH segments
1992 StandoutNobel
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients
2008
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
The double edged sword of the immune response: mutational analysis of a murine anti-pneumococcal, anti-DNA antibody.
1996
VHGenes of Human Autoantibodies
1990
Infection in Solid-Organ Transplant Recipients
2007 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients<SUBTITLE>A 3-Year Randomized Trial</SUBTITLE>
2004
The health and health system of South Africa: historical roots of current public health challenges
2009 Standout
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy
2009
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
2022
Global tuberculosis drug development pipeline: the need and the reality
2010
Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs
2004
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites
1992
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
The genetics and pathology of oxidative phosphorylation
2001
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
2006
The Pathophysiology of Mitochondrial Cell Death
2004 StandoutScience
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Defective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathy
2003
Therapeutic drug monitoring of antiretrovirals for people with HIV
2009
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
2016 Standout
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up
2008
Cannabis in painful HIV-associated sensory neuropathy
2007
Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
2007
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Review : Serological markers of disease activity in systemic lupus erythematosus
1995
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories
2004
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
High Seroprevalence But Low Incidence of HCV Infection in a Cohort of Patients With Sexually Transmitted HIV in Andalusia, Spain
2009
IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus
1991
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
2003 StandoutScience
Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
1993
Competing risks and the clinical community: irrelevance or ignorance?
2011
Computerized advice on drug dosage to improve prescribing practice
2008
Antiretroviral drugs and liver injury
2008
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Quality Control Assessment of Human Immunodeficiency Virus Type 2 (HIV-2) Viral Load Quantification Assays: Results from an International Collaboration on HIV-2 Infection in 2006
2008
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2009
Body Habitus Changes and Metabolic Alterations in Protease Inhibitor–Naive HIV-1–Infected Patients Treated With Two Nucleoside Reverse Transcriptase Inhibitors
2002
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Cannabinoids for Medical Use
2015 Standout
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Quinolone 3-Carboxylic Acid Pharmacophore: Design of Second Generation HIV-1 Integrase Inhibitors
2008
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
2009
Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus.
1991
Catalytic Asymmetric Protonation of Silyl Ketene Imines
2013 StandoutNobel
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
2007
Neuropsychiatric manifestations of HIV infection and AIDS
2005
Use of Glomerular Filtration Rate Estimating Equations for Drug Dosing in HIV-Positive Patients
2013
Synthetic Nanoparticles for Vaccines and Immunotherapy
2015
Works of Kees Brinkman being referenced
Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity
1990
Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations
1990
A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function
2011
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals
2003
Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
1999
Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss
2009
Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes
1990
Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort
2002
Clinical experience with the combined use of lopinavir/ritonavir and rifampicin
2009
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals
2010
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir
2009
Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration
2011
Change to abacavir-lamivudine-tenofovir combination treatment in patients with HIV-1 who had complete virological suppression
2003
Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort
2002
Mortality and progression to AIDS after starting highly active antiretroviral therapy
2003
Anti-dsDNA: choice of assay in relation to clinical value
1991
Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus
2005
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM
2011
Increase in HCV Incidence among Men Who Have Sex with Men in Amsterdam Most Likely Caused by Sexual Transmission
2007
Highly active antiretroviral therapy (HAART) among HIV‐infected drug users: a prospective cohort study of sexual risk and injecting behaviour
2006
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients
2003
Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?
2000
Adverse effects of reverse transcriptase inhibitors
1998
Discontinuation of Nevirapine Because of Hypersensitivity Reactions in Patients with Prior Treatment Experience, Compared with Treatment-Naive Patients: The ATHENA Cohort Study
2008
Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
2009
Adenosine-Induced Atrial Arrhythmia: A Prospective Analysis
1997
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.
2005
Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases
2000
Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients.
1998
Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple Therapy
1998
Reaction patterns of monoclonal antibodies to DNA.
1988
Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation
1998
Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure
2000